Join AlphaMaven

The Home Of Managed Futures

Register For Free Learn More Contact Us

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Managed Futures Dashboard:

Click to subscribe to our Free Daily Newsletter

Top Managed Futures News, Listings, Member Posts, Managed Futures Daily Indices and more!

Butler and Buck Back to Bookend 2020
3yrs ago Managed Futures rcmalternatives Views: 370

We’ve already covered the first three months of 2020 with Part I of our 2020 review. We’re now heading into Part II with Jason Buck, CIO at Mutiny Fund and Adam Butler, CIO at ReSolve Asset Management discussing how the fall out of the first three months of 2020 dictated the ending 3/4 of the year. Tune into this next episode to hear more on the possible bond fallout, stimulus holding US markets hostage, the future of the traditional 60/40 portfolio, ReSolve’s Riffs, do deficits matter?, commodity’s role in inflation, “am I a socialist?,” technology improvements in commodity production, the Mutiny Podcast, and the VIX at all-time highs – and what that really means.

https://www.rcmalternatives.com/wp-content/uploads/2020/12/2020-Review-Part-2-snip.mp4

 

Find the full episode links below:

 

 

Follow along with Adam on Twitter and LinkedIn, and with ReSolve on their website and their ReSolve’s Riffs series.

 

Follow along with Jason on Twitter and LinkedIn and with Mutiny Fund on their website and the Mutiny Fund podcast.

 

And last but not least, don’t forget to subscribe to The Derivative, and follow us on Twitter, or LinkedIn, and Facebook, and sign-up for our blog digest.

 

Butler and Buck Back to Bookend 2020 first appeared on RCM Alternatives.

Today's Managed Futures Headlines:

Most popular| Most recent
FEATURED MEMBER POST
Andrea Alms Video:  Money In Motion 96 - Bone Marrow Transplantation Market
Private Equity BrookDell Partners #Video
Winton 25 March Delighted to join the alumni gathering of our Master of Science in Asset and Wealth Management (MAWM) Programme with Nanyang Technological University Singapore. NTU-WMI launched this programme in 2018, and it was a first-of-its-kind post-experience Master's degree with IBF subsidies of up to 70% for Singaporeans and PRs.
4d ago Managed Futures linkedin
Asset Class Scoreboard: March 2024
1w ago Managed Futures rcmalternatives
Softs Report 04/09/2024
1w ago Managed Futures blog.pricegroup
Fresh from the Trading Room: If you ain't first, you're last
1w ago Managed Futures cmegroup
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
RECEIVE FREE NEWSLETTER
View Managed Futures Listings
AlphaMaven Daily Indices
Apr MTD ROR
AlphaMaven Managed Futures Index:
1.5%
- more -
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 96 - Bone Marrow Transplantation Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 102 - Deep Dive Immunotherapy Cancer Market Part 3
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 100 - Cancer Market Wrap-Up
- posted by: BrookDell Partners
Ridgedale Co-CIO Newsletter February 2024
- posted by: Ridgedale Advisors
Exome Worldwide Healthcare Partners - March 2024 Investor Newsletter
- posted by: Worldwide Healthcare Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.